FindTrial
Sign In

Diagnostic value of pleural effusion IGRA test in patients with tuberculous pleurisy

Diagnostic value of pleural effusion IGRA test in patients with tuberculous pleurisy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DPD-15006406
Enrollment
Unknown
Registered
2015-05-18
Start date
2015-06-01
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pleural Tuberculosis

Interventions

Gold Standard:pathological diagnosis
Chest X-ray
Index test:IGRA test

Sponsors

Beijing Chest Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients in tuberculous pleurisy group should be consistent with clinical diagnostic standard; and the control group subjects should have pathological diagnosis of malignant pleural effusion; 2. The extraction quantity of pleural effusion is over 100ml in localizable cases; 3. Aged between 18 to 65 years; 4. HIV(-).

Exclusion criteria

Exclusion criteria: 1. Tuberculous empyema; 2. Being too weakness to withstand the thoracentesis; 3. Using hormone or other immunosuppressants in the past 6 months.

Design outcomes

Primary

MeasureTime frame
The result of GeneXpert;—

Countries

China

Contacts

Public ContactCHEN Xiao-you

Beijing Chest Hospital, Capital Medical University

chenxy1998@hotmail.com+86 010-89509343

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026